TNA
TMO icon

True North Advisors’s Thermo Fisher Scientific TMO Stock Holding History

True North Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
1,170
+185
+19% +$88.8K 0.06% 161
2026
Q1 		$484K Sell
985
-76
-7% -$41.2K 0.06% 169
2025
Q4 		$615K Buy
1,061
+117
+12% +$66.2K 0.08% 143
2025
Q3 		$458K Buy
944
+418
+79% +$195K 0.07% 139
2025
Q2 		$213K Sell
526
-149
-22% -$62.3K 0.04% 215
2025
Q1 		$336K Buy
675
+51
+8% +$27.6K 0.06% 174
2024
Q4 		$325K Buy
624
+55
+10% +$30.2K 0.08% 132
2024
Q3 		$352K Sell
569
-87
-13% -$51.5K 0.09% 121
2024
Q2 		$363K Buy
656
+9
+1% +$5.16K 0.1% 124
2024
Q1 		$376K Sell
647
-38
-6% -$21.3K 0.1% 118
2023
Q4 		$364K Sell
685
-62
-8% -$30K 0.09% 121
2023
Q3 		$378K Buy
747
+79
+12% +$42.1K 0.12% 126
2023
Q2 		$348K Buy
+668
New +$360K 0.1% 148

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

True North Advisors's TMO Position: Q2 2026 in Review

True North Advisors increased its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, buying an estimated $88.8K and bringing the position to 1,170 shares worth $587K. The position accounts for 0.06% of the portfolio, ranked #161.

True North Advisors first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $615K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • True North Advisors held 1,170 shares of Thermo Fisher Scientific worth $587K as of Q2 2026.
  • True North Advisors bought 185 Thermo Fisher Scientific shares in Q2 2026, an estimated $88.8K.
  • Thermo Fisher Scientific made up 0.06% of True North Advisors's portfolio in Q2 2026, its #161 holding.
  • True North Advisors first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • True North Advisors's Thermo Fisher Scientific position peaked at $615K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.